TCG Advisory Services LLC grew its position in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 72.8% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 7,448 shares of the company’s stock after acquiring an additional 3,137 shares during the period. TCG Advisory Services LLC’s holdings in Colgate-Palmolive were worth $594,000 at the end of the most recent quarter.
Other institutional investors have also recently made changes to their positions in the company. Morgan Stanley lifted its position in Colgate-Palmolive by 3.2% during the 3rd quarter. Morgan Stanley now owns 16,815,987 shares of the company’s stock valued at $1,195,785,000 after acquiring an additional 514,559 shares during the period. Northern Trust Corp boosted its holdings in Colgate-Palmolive by 3.3% in the third quarter. Northern Trust Corp now owns 9,452,931 shares of the company’s stock worth $672,198,000 after acquiring an additional 305,862 shares in the last quarter. American Century Companies Inc. grew its stake in shares of Colgate-Palmolive by 2.0% in the third quarter. American Century Companies Inc. now owns 6,590,405 shares of the company’s stock worth $468,644,000 after acquiring an additional 127,805 shares during the last quarter. FMR LLC increased its holdings in shares of Colgate-Palmolive by 27.3% during the third quarter. FMR LLC now owns 5,597,742 shares of the company’s stock valued at $398,055,000 after acquiring an additional 1,199,660 shares in the last quarter. Finally, Nordea Investment Management AB raised its position in shares of Colgate-Palmolive by 10.1% in the 3rd quarter. Nordea Investment Management AB now owns 5,455,384 shares of the company’s stock worth $390,005,000 after purchasing an additional 500,916 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.
Insider Transactions at Colgate-Palmolive
In other Colgate-Palmolive news, insider Jennifer Daniels sold 3,538 shares of the stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $84.67, for a total value of $299,562.46. Following the completion of the sale, the insider now owns 59,698 shares in the company, valued at approximately $5,054,629.66. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other news, insider Jennifer Daniels sold 3,538 shares of the business’s stock in a transaction on Tuesday, February 20th. The shares were sold at an average price of $84.67, for a total value of $299,562.46. Following the transaction, the insider now owns 59,698 shares of the company’s stock, valued at $5,054,629.66. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Noel R. Wallace sold 69,948 shares of Colgate-Palmolive stock in a transaction dated Tuesday, February 20th. The stock was sold at an average price of $84.22, for a total value of $5,891,020.56. Following the completion of the sale, the chief executive officer now directly owns 286,881 shares in the company, valued at $24,161,117.82. The disclosure for this sale can be found here. Insiders sold a total of 159,048 shares of company stock valued at $13,336,846 over the last three months. Corporate insiders own 0.34% of the company’s stock.
Wall Street Analysts Forecast Growth
Check Out Our Latest Report on CL
Colgate-Palmolive Stock Performance
Shares of CL traded down $0.03 on Friday, reaching $92.88. The company’s stock had a trading volume of 5,432,695 shares, compared to its average volume of 4,878,342. The stock’s 50 day simple moving average is $88.35 and its two-hundred day simple moving average is $82.35. The company has a debt-to-equity ratio of 13.21, a current ratio of 1.06 and a quick ratio of 0.28. The stock has a market capitalization of $76.20 billion, a P/E ratio of 29.39, a PEG ratio of 3.43 and a beta of 0.40. Colgate-Palmolive has a 12-month low of $67.62 and a 12-month high of $93.25.
Colgate-Palmolive (NYSE:CL – Get Free Report) last issued its quarterly earnings results on Friday, April 26th. The company reported $0.86 earnings per share for the quarter, topping the consensus estimate of $0.82 by $0.04. The business had revenue of $5.07 billion for the quarter, compared to analysts’ expectations of $4.96 billion. Colgate-Palmolive had a net margin of 13.22% and a return on equity of 485.40%. The company’s revenue was up 6.2% compared to the same quarter last year. During the same quarter last year, the company posted $0.73 EPS. Research analysts forecast that Colgate-Palmolive will post 3.52 earnings per share for the current fiscal year.
Colgate-Palmolive Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Monday, April 22nd will be paid a dividend of $0.50 per share. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.48. The ex-dividend date is Friday, April 19th. This represents a $2.00 dividend on an annualized basis and a yield of 2.15%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 63.29%.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
See Also
- Five stocks we like better than Colgate-Palmolive
- Quiet Period Expirations Explained
- MarketBeat Week in Review – 4/29 – 5/3
- 3 Warren Buffett Stocks to Buy Now
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- Transportation Stocks Investing
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.